Q2 EPS Estimates for Ovid Therapeutics Cut by William Blair
Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Equities researchers at William Blair decreased their Q2 2025 earnings estimates for shares of Ovid Therapeutics in a research report issued to clients and investors on Wednesday, March 12th. William Blair analyst S. Schram now anticipates that the company will earn ($0.15) per share for the quarter, […]
Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Equities researchers at William Blair decreased their Q2 2025 earnings estimates for shares of Ovid Therapeutics in a research report issued to clients and investors on Wednesday, March 12th. William Blair analyst S. Schram now anticipates that the company will earn ($0.15) per share for the quarter, […]
